VSee Health Reports 33.61% Stock Surge Amid SEC Filings

Introduction to VSee Health Inc.

VSee Health Inc (NASDAQ: VSEE) is a digital health company founded in 2008 that provides a HIPAA-compliant telemedicine platform. The no-code, low-code solution supports video visits, patient engagement, scheduling, and integration with electronic health records. Its services encompass urgent care, telepsychiatry, chronic care management, and remote physician teams. VSee’s technology is utilized by clients such as NASA, McKesson, GE Health, and Optum, and the platform has been deployed on the International Space Station since 2014.

Corporate Structure and Experience

Headquartered in California, VSee employs between 51 and 200 people, attracting talent with backgrounds in software development, healthcare, and engineering. The company is led by Co-CEOs Dr. Milton Chen (PhD, Stanford) and Dr. Imoigele Aisiku (MD, Harvard Medical/Brigham and Women’s), who oversee both the core telehealth platform and the iDoc physician services. The board of directors includes healthcare executives and academics such as Kevin Lowdermilk, Scott Metzger, MD, and Colin O’Sullivan, DHA, FACHE, providing expertise in finance, clinical care, and hospital administration.

Telemedicine by Mary Eineman

Recent Developments and News

• On April 1, 2025, VSee filed a Form NT 10-K notifying the SEC of a delay in its annual report due to the completion of audited financial statements following its June 2024 de-SPAC merger.
• On May 8 and May 30, 2025, the company submitted two Form 8-K current reports under Item 3.01, indicating material events affecting its securities; specific details require review of the filings.
• In June 2023, VSee was selected by Health Tech Without Borders as the technology partner for its Clinton Global Initiative commitment in Cameroon.
• Since 2014, VSee’s video platform has supported telemedicine visits and communications on the International Space Station.

Financial and Strategic Aspects

As of July 14, 2025, VSee shares closed at $1.63, reflecting a 33.61% increase on a volume of 6,069,714 traded shares. The April NT 10-K indicates that VSee is working with auditors to finalize its Form 10-K within the 15-day extension allowed under Rule 12b-25. Strategically, the company focuses on rapid deployment of white-label telehealth applications via APIs and SDKs, expansive clinician services (iDoc), and partnerships that enhance its market presence. Its low-cost, configurable platform is designed to reduce development cycles and enable healthcare providers to adjust workflows without programming knowledge.

Market Position and Industry Context

VSee operates in a competitive telemedicine landscape alongside platforms such as Zoom for Healthcare, Amwell, and Teladoc. Its differentiators include in-house video streaming optimized for concurrent medical device data, extensive EHR integration, and a client-focused approach emphasizing no-code configurability. By serving over 2,000 organizations—including government agencies, nonprofits, and hospital systems—VSee occupies a niche focused on customizable telehealth solutions. Ongoing innovations in AI-driven clinical decision support (VSee AI Journal) and initiatives aimed at health equity contribute to its positioning within the broader digital health transformation trend.

TL;DR

On July 14, 2025, VSee’s stock increased 33.61% to $1.63 on significant trading volume. The company is completing its audited 2024 financial statements and plans to file its Form 10-K within the SEC’s 15-day extension following an April 1 NT 10-K notice linked to its June 2024 de-SPAC merger. VSee continues to expand telehealth deployments from the International Space Station to global nonprofit partnerships while progressing its no-code platform and clinician services.